Atlas Trials

Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia

Clinical trial NCT00056433 · COMPLETED

Trial details

NCT number
NCT00056433
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sickle Cell Anemia
Start date
2003-03-10
Primary completion
2006-12-27
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.